E154 E146 LANCET HIV, 5(3), E146-E154. Elsevier Ltd. Phillips, A N, Cambiano, V, Nakagawa, F, Revill, P, Jordan, M R, Hallett, T B, Doherty, M, De Luca, A, Lundgren, J D, Mhangara, M, Apollo, T, Mellors, J, Nichols, B, Parikh, U, Pillay, D, Rinke de Wit, T, Sigaloff, K, Havlir, D, Kuritzkes, D R, Pozniak, A, van de Vijver, D, Vitoria, M, Wainberg, M A, Raizes, E, Bertagnolio, S & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa 2018, ' Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa : a modelling study ', The Lancet HIV, vol. 5, no. 3, pp. e146-e154 . https://doi.org/10.1016/S2352-3018(17)30190-X